Altimmune share price today

(ALT)

Altimmune share price is $8.25 & ₹701.05 as on 21 Dec 2024, 2.30 'hrs' IST

$8.25

▲

0.07

(0.86%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Altimmune share price in Dollar and Rupees. Guide to invest in Altimmune from India. Also see the sentimental analysis on Indian investors investing in Altimmune. Get details on the Indian mutual funds that are investing in Altimmune. Get Analyst recommendations and forecasts along with all the Altimmune's financials.

Altimmune share price movements

Today's Low: $8.18
Today's High: $8.74
$8.25
0.85%
Downside
Day's Volatility :6.41%
Upside
5.61%
52 Weeks Low: $5.28
52 Weeks High: $14.84
$8.25
36.06%
Downside
52 Weeks Volatility :64.45%
Upside
44.41%

Altimmune Returns

Period	Altimmune Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	14.58%	-11.1%	0.0%
6 Months	15.55%	-6.0%	0.0%
1 Year	-11.0%	2.7%	0.0%
3 Years	-10.23%	0.6%	-19.7%

Altimmune Key Statistics

in dollars & INR

Previous Close	$8.18
Open	$8.31
Today's High	$8.7402
Today's Low	$8.18
Market Capitalization	$561.9M
Today's Volume	$4.7M
52 Week High	$14.84
52 Week Low	$5.275
Revenue TTM	$52.0K
EBITDA	$-99.2M
Earnings Per Share (EPS)	$-1.57
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-72.96%

How to invest in Altimmune from India?

It is very easy for Indian residents to invest directly in Altimmune from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Altimmune stock in both Indian Rupees (INR) and US Dollars (USD). Search for Altimmune or ALT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Altimmune or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Altimmune shares which would translate to 0.103 fractional shares of Altimmune as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Altimmune, in just a few clicks!

Returns in Altimmune for Indian investors in Rupees

Investment Value

₹1,00,000

Altimmune investment value today

Current value as on today

₹1,13,199

Returns

₹13,199

(+13.2%)

Returns from Altimmune Stock

₹11,003 (false-11%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Altimmune

-14.5%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Altimmune from India has reduced in the last 30 days as on Dec 21, 2024. -14.5% less purchase transactions for Altimmune in the last 30 days versus the previous period.

54%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Altimmune on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 54% more investors are searching Altimmune in the last 30 days versus the previous period.

Global Institutional Holdings in Altimmune

BlackRock Inc
7.48%
Vanguard Group Inc
7.01%
Ameriprise Financial Inc
5.45%
State Street Corp
4.80%
TANG CAPITAL MANAGEMENT LLC
3.87%
Geode Capital Management, LLC
2.35%

Analyst Recommendation on Altimmune

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Altimmune(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Altimmune

What analysts predicted

Upside of 177.06%

Current:

$8.25

Target:

$22.86

Insights on Altimmune

Price Movement
In the last 7 days, ALT stock has moved down by -8.6%
Decreasing Revenue
Revenue is down for the last 5 quarters, 362.0K → 5.0K (in $), with an average decrease of 44.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -24.64M → -22.84M (in $), with an average increase of 7.9% per quarter
ALT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 30.9%
ALT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 33.5%
Price to Sales
ForALT every $1 of sales, investors are willing to pay $8250.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Altimmune Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.3M	↑ 24792.58%
Net Income	$-39.2M	↓ 15.63%
Net Profit Margin	-379.16%	↑ 111481.16%

	FY19	Y/Y Change
Revenue	$5.8M	↓ 43.85%
Net Income	$-20.5M	↓ 47.61%
Net Profit Margin	-353.71%	↑ 25.45%

	FY20	Y/Y Change
Revenue	$8.2M	↑ 41.09%
Net Income	$-49.0M	↑ 139.01%
Net Profit Margin	-599.2%	↓ 245.49%

	FY21	Y/Y Change
Revenue	$4.4M	↓ 46.12%
Net Income	$-96.2M	↑ 96.09%
Net Profit Margin	-2.2K%	↓ 1581.38%

	FY22	Y/Y Change
Revenue	$-68.0K	↓ 101.54%
Net Income	$-84.7M	↓ 11.91%
Net Profit Margin	124.6K%	↑ 126758.52%

	FY23	Y/Y Change
Revenue	$426.0K	↓ 726.47%
Net Income	$-88.4M	↑ 4.41%
Net Profit Margin	-20.8K%	↓ 145340.15%

	Q2 FY23	Q/Q Change
Revenue	$6.0K	↓ 71.43%
Net Income	$-16.1M	↓ 12.67%
Net Profit Margin	-267.7K%	↓ 180107.14%

	Q3 FY23	Q/Q Change
Revenue	$362.0K	↑ 5933.33%
Net Income	$-20.7M	↑ 28.7%
Net Profit Margin	-5.7K%	↑ 261973.11%

	Q4 FY23	Q/Q Change
Revenue	$37.0K	↓ 89.78%
Net Income	$-31.6M	↑ 53.07%
Net Profit Margin	-85.5K%	↓ 79806.0%

	Q1 FY24	Q/Q Change
Revenue	$5.0K	↓ 86.49%
Net Income	$-24.4M	↓ 22.9%
Net Profit Margin	-487.9K%	↓ 402363.78%

	Q2 FY24	Q/Q Change
Revenue	$5.0K	↑ 0.0%
Net Income	$-24.6M	↑ 1.01%
Net Profit Margin	-492.8K%	↓ 4920.0%

	Q3 FY24	Q/Q Change
Revenue	$5.0K	↑ 0.0%
Net Income	$-22.8M	↓ 7.28%
Net Profit Margin	-456.9K%	↑ 35900.0%

	FY18	Y/Y Change
Profit	$10.3M	↓ 156.26%

	FY19	Y/Y Change
Profit	$-11.3M	↓ 209.03%

	FY20	Y/Y Change
Profit	$-25.3M	↑ 124.82%

	FY21	Y/Y Change
Profit	$3.9M	↓ 115.24%

	FY22	Y/Y Change
Profit	$-136.0K	↓ 103.52%

	FY23	Y/Y Change
Profit	$-51.0K	↓ 62.5%

	Q2 FY23	Q/Q Change
Profit	$-13.2M	↓ 3613.79%

	Q3 FY23	Q/Q Change
Profit	$-18.0M	↑ 36.08%

	Q4 FY23	Q/Q Change
Profit	$-1.9M	↓ 89.72%

	Q1 FY24	Q/Q Change
Profit	$-102.0K	↓ 94.5%

	Q2 FY24	Q/Q Change
Profit	$-56.0K	↓ 45.1%

	Q3 FY24	Q/Q Change
Profit	$5.0K	↓ 108.93%

	FY18	Y/Y Change
Operating Cash Flow	$-9.4M	↓ 53.55%
Investing Cash Flow	$-1.0M	↓ 107.29%
Financing Cash Flow	$32.5M	↑ 105.1%

	FY19	Y/Y Change
Operating Cash Flow	$-9.6M	↑ 2.27%
Investing Cash Flow	$-28.3M	↑ 2725.41%
Financing Cash Flow	$12.5M	↓ 61.43%

	FY20	Y/Y Change
Operating Cash Flow	$-34.4M	↑ 258.64%
Investing Cash Flow	$-72.1M	↑ 154.88%
Financing Cash Flow	$213.5M	↑ 1603.52%

	FY21	Y/Y Change
Operating Cash Flow	$-78.2M	↑ 127.19%
Investing Cash Flow	$87.5M	↓ 221.4%
Financing Cash Flow	$65.1M	↓ 69.51%

	FY22	Y/Y Change
Operating Cash Flow	$-62.6M	↓ 20.01%
Investing Cash Flow	$-73.4M	↓ 183.86%
Financing Cash Flow	$56.8M	↓ 12.78%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-19.4M	↓ 0.12%
Investing Cash Flow	$4.0M	↓ 70.03%
Financing Cash Flow	$13.2M	↓ 4683.74%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-20.5M	↑ 5.7%
Investing Cash Flow	$4.4M	↑ 10.41%
Financing Cash Flow	$588.0K	↓ 95.56%

Altimmune Technicals Summary

Sell

Neutral

Buy

Altimmune is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Altimmune Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Altimmune Inc	-1.84%	15.55%	-11.0%	-10.23%	366.1%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Altimmune Inc	NA	NA	0.0	-1.34	-0.73	-0.4	NA	1.88
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Altimmune Inc	Buy	$561.9M	366.1%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Altimmune

altimmune, inc. is a clinical stage biotechnology company developing next-generation immunotherapeutics and vaccines to address significant public health and biodefense needs. by leveraging specific attributes of its two independent and complementary platform technologies, altimmune can rapidly design product candidates against a wide range of disease targets, including respiratory diseases, chronic infections, and cancer. our densigen™ t-cell platform technology is uniquely suited to direct the immune response against traditionally difficult disease targets, including chronic infections and cancer, by directing an individual’s immune system against multiple target antigens instead of just one. altimmune’s respirvec™ platform utilizes convenient needle-free intranasal delivery to achieve broad immunity against disease pathogens more rapidly than conventional vaccines. vaxin’s product candidates are easily manufactured, highly stable, and provide a safe, effective alternative to current

Organization	Altimmune
Employees	59
CEO	Dr. Vipin K. Garg Ph.D.
Industry	Commercial Services

Management People of Altimmune

Name	Title
Dr. Vipin K. Garg Ph.D.	President, CEO & Director
Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS	Chief Medical Officer
Mr. Raymond M. Jordt M.B.A.	Chief Business Officer
Mr. Gregory L. Weaver CPA, M.B.A.	Chief Financial Officer
Mr. Andrew Shutterly M.S.	Principal Financial & Accounting Officer and Corporate Controller
Mr. Bertrand Georges Ph.D.	Chief Technology Officer
Dr. M. Scot Roberts Ph.D.	Chief Scientific Officer
Mr. Tony Blandin B.S.	Vice President of Quality & Compliance Management

Important FAQs about investing in Altimmune from India :

What is Altimmune share price today?

Altimmune share price today stands at $8.25, Open: $8.31 ; Previous Close: $8.18 ; High: $8.74 ; Low: $8.18 ; 52 Week High: $14.84 ; 52 Week Low: $5.28. The stock opens at $8.31, after a previous close of $8.18. The stock reached a daily high of $8.74 and a low of $8.18, with a 52-week high of $14.84 and a 52-week low of $5.28.

Can Indians buy Altimmune shares?

Yes, Indians can invest in the Altimmune (ALT) from India.

With INDmoney, you can buy Altimmune at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Altimmune at zero transaction cost.

How can I buy Altimmune shares from India?

It is very easy to buy Altimmune from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Altimmune be purchased?

Yes, you can buy fractional shares of Altimmune with INDmoney app.

What are the documents required to start investing in Altimmune stocks?

To start investing in Altimmune, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.